UCLA's Jonsson Comprehensive Cancer Center : JCCC Member Directory

Robert M. Elashoff, Ph.D.

Affiliation(s):

Professor, Department of Biostatistics, Department of Biomathematics

Leader, UCLA Clinical and Translational Science Institute (CTSI) Joint Biostatistics Program

Co-Director, JCCC Biostatistics, Analytic Support and Evaluation (BASE) Shared Resource

Director, JCCC Protocol Review and Monitoring System Shared Resource

Member, JCCC Community

Contact Information:

Phone:	(310) 794-5861
Email:	relashof@biomath.ucla.edu

Scientific Interest(s):

Dr. Robert Elashoff's research focuses on survival analysis, repeated measure analysis and clinical trial design and analysis.

Selected Cancer-Related Publications:

Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011 Jul;141(1):150-6. Epub 2011 Feb 18.

Mao JT, Roth MD, Fishbein MC, Aberle DR, Zhang ZF, Rao JY, Tashkin DP, Goodglick L, Holmes EC, Cameron RB, Dubinett SM, Elashoff R, Szabo E, Elashoff D. Lung cancer chemoprevention with celecoxib in former smokers. Cancer Prev Res (Phila). 2011 Jul;4(7):984-93.

Chang HR, Glaspy J, Allison MA, Kass FC, Elashoff R, Chung DU, Gornbein J. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment. Cancer. 2010 Sep 15;116(18):4227-37.

Faries MB, Thompson JF, Cochran A, Elashoff R, Glass EC, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Wang HJ, Morton DL; MSLT Cooperative Group. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010 Dec;17(12):3324-9. Epub 2010 Jul 8.

Elashoff RM, Li G, Li N. An approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med. 2007; 26(14): 2813-35.